PYC Therapeutics Limited announced the appointment of Jason Haddock to its Board of Directors. Mr. Haddock brings more than two decades of financial, commercial and operational leadership experience in the biopharmaceutical industry, and currently serves as a Board Director of Codiak BioSciences, a biotech company developing precision exosome therapeutics. Throughout his career, Mr. Haddock has held a variety of leadership roles at biopharma companies, overseeing finance, commercial and business development strategies in the U.S. and worldwide. Previously, he was Chief Financial Officer at Array Biopharma, where he was instrumental in developing a research, development and commercialization strategy that culminated in the successful launch and commercialization of two oncology therapies and Array's acquisition by Pfizer for $11.4 billion.